Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 23, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 1, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 25, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 3, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 2, 2011View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 31, 2011View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesOct 31, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 27, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 26, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 11, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 5, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 30, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 29, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 26, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 12, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 6, 2011View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderSep 6, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 1, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 31, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 22, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2011View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsAug 10, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 4, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 4, 2011View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-115

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information